| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,301 |
6,716 |
$770K |
| G0378 |
Hospital observation service, per hour |
1,550 |
1,389 |
$744K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,383 |
3,128 |
$472K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,022 |
4,567 |
$343K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,990 |
5,516 |
$150K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,729 |
1,374 |
$75K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,123 |
988 |
$42K |
| 90834 |
Psychotherapy, 45 minutes with patient |
374 |
219 |
$40K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,537 |
514 |
$26K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,704 |
2,311 |
$25K |
| C7901 |
Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service |
220 |
188 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
3,446 |
3,268 |
$9K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
512 |
221 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,870 |
6,825 |
$8K |
| 82803 |
|
125 |
111 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,313 |
9,293 |
$5K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
676 |
645 |
$4K |
| 84484 |
|
5,078 |
4,238 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,253 |
10,305 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
775 |
256 |
$3K |
| 97161 |
|
42 |
40 |
$2K |
| 85379 |
|
904 |
864 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
24 |
24 |
$2K |
| 83880 |
|
1,182 |
1,127 |
$1K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,620 |
1,529 |
$1K |
| 73562 |
|
304 |
252 |
$888.13 |
| 71045 |
Radiologic examination, chest; single view |
2,511 |
2,312 |
$810.19 |
| 83605 |
|
1,389 |
1,211 |
$775.37 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
216 |
203 |
$638.73 |
| 94760 |
|
80 |
51 |
$627.72 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
376 |
352 |
$621.24 |
| 80076 |
|
2,712 |
2,451 |
$508.39 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,376 |
1,291 |
$432.53 |
| 73630 |
|
140 |
119 |
$428.95 |
| 81025 |
|
493 |
445 |
$427.59 |
| 73610 |
|
28 |
27 |
$425.18 |
| 81001 |
|
2,712 |
2,515 |
$424.41 |
| 83690 |
|
2,500 |
2,304 |
$376.42 |
| 85610 |
|
4,289 |
2,935 |
$328.83 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
209 |
200 |
$278.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,509 |
1,620 |
$245.36 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,554 |
2,351 |
$231.49 |
| 81003 |
|
1,895 |
1,765 |
$217.76 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
507 |
497 |
$198.84 |
| 80053 |
Comprehensive metabolic panel |
1,112 |
946 |
$189.44 |
| 83735 |
|
3,117 |
2,177 |
$180.10 |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,161 |
1,129 |
$102.57 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,155 |
1,923 |
$72.97 |
| 86850 |
|
57 |
51 |
$72.14 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
24 |
24 |
$60.55 |
| 86140 |
|
18 |
17 |
$52.60 |
| 84100 |
|
1,331 |
824 |
$47.64 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,107 |
910 |
$42.11 |
| 84443 |
Thyroid stimulating hormone (TSH) |
150 |
136 |
$41.13 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
362 |
350 |
$33.86 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
432 |
396 |
$32.47 |
| 86901 |
|
29 |
25 |
$22.24 |
| 86900 |
|
29 |
25 |
$22.24 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
606 |
505 |
$20.31 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,136 |
1,007 |
$14.33 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,501 |
1,396 |
$7.54 |
| J7050 |
Infusion, normal saline solution, 250 cc |
443 |
302 |
$4.57 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
27 |
24 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
265 |
254 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
75 |
63 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
162 |
127 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
105 |
101 |
$0.00 |
| J3490 |
Unclassified drugs |
613 |
450 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
40 |
37 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
92 |
87 |
$0.00 |
| 93458 |
|
13 |
13 |
$0.00 |
| 82077 |
|
77 |
67 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
136 |
107 |
$0.00 |
| C1769 |
Guide wire |
34 |
29 |
$0.00 |
| 84132 |
|
48 |
48 |
$0.00 |
| 87428 |
|
68 |
68 |
$0.00 |
| 87581 |
|
24 |
24 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
43 |
40 |
$0.00 |
| 87070 |
|
14 |
14 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
30 |
24 |
$0.00 |
| 94762 |
|
24 |
24 |
$0.00 |
| 87486 |
|
12 |
12 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
14 |
14 |
$0.00 |
| 87077 |
|
12 |
12 |
$0.00 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
17 |
17 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
24 |
24 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
161 |
143 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
87 |
80 |
$0.00 |
| 73030 |
|
46 |
42 |
$0.00 |
| 73130 |
|
46 |
40 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
134 |
122 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
196 |
186 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
62 |
61 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
78 |
40 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
27 |
24 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
34 |
33 |
$0.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
22 |
12 |
$0.00 |
| 87186 |
|
12 |
12 |
$0.00 |